Dr. Andrew Philip Jallouk, MD, PhD

Dr. Jallouk practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Jallouk's NPI, 1609396753, was assigned on June 20, 2017. Dr. Jallouk holds Tennessee license 68310.

Dr. Jallouk's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Jallouk's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. Dr. Jallouk is also affiliated with West Tennessee Healthcare Jackson-Madison County General Hospital. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Jallouk to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jallouk practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Jallouk's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Jallouk's licenses on file in 2 states: Tennessee and Texas.

CMS data shows 466 Medicare services from Dr. Jallouk across 5 procedure codes in 2024, for 89 Medicare patients. Medicare paid $36,427 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 89 Medicare patients who saw Dr. Jallouk in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jallouk's median patient age at 68, with 38% women.

In 2024, Dr. Jallouk wrote 317 Medicare Part D claims for 52 patients. 84% of them were for generic drugs. CMS names the drug for 166 of them, across 7 drugs with 11 or more claims each, at $169,992 in total drug cost. In 2022, CMS named 39 claims across 3 drugs.

Dr. Jallouk accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jallouk as offering telehealth.

Dmand AI links 20 papers to Dr. Jallouk, published from 2012 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Immunotherapy, Adoptive, Lymphoma, Large B-Cell, Diffuse and Antigens, CD19. Dr. Jallouk has published most often in Bone Marrow Transplant. Dr. Jallouk's most frequent co-authors are Bhagirathbhai Ravjibhai Dholaria, MD, Samuel A. Wickline, MD and Sairah Ahmed, MD.

CMS Open Payments shows 19 general payments to Dr. Jallouk from 5 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 79% of the total. Kite Pharma, Inc. paid the most, $4,882. It also lists 6 research payments totaling $932 in 2024, naming 2 clinical trials.